Taproot Medical Technologies is a stealth-mode company developing biocompatible, nonfouling and self-sterilizing biomaterials intended for medical applications. Its work focuses on molecular design principles to prevent nonspecific biomolecule and microorganism attachment and to ensure compatibility with biomolecules, cells, and tissues. Research linked to the company emphasizes materials that may have self-sterilizing capabilities and other properties that could help prevent infection. The company was founded in 2016 and is headquartered in Shoreline, Washington. Officers named in an SEC filing include Jens Quistgaard and University of Washington professor Shaoyi Jiang; senior scientist Andy Sinclair is listed as working at the company. Financially, Taproot has raised $1.25 million of a planned $2.25 million round, its first fundraising since founding, according to the filing.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2018